Related Experiment Video
Updated: Sep 2, 2025

11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
46.9K
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients
Christina Hunter Chapman1,2, Reshma Jagsi1, Kent A Griffith1
1Rogel Comprehensive Cancer Center at the University of Michigan, Ann Arbor, MI, USA.
Journal of the National Cancer Institute
|August 2, 2022
Summary
Black and Asian women receiving breast cancer radiation therapy experienced higher heart radiation doses, potentially leading to increased cardiac events and deaths. Addressing disparities in cardiac risk factors and radiation technology use is crucial.
Area of Science:
- Oncology
- Radiotherapy
- Cardiovascular Health
Background:
- Racial disparities in cancer survival necessitate research into treatment inequities.
- Previous studies have not assessed cardiac radiation dose by race in large breast cancer cohorts.
- Understanding dose disparities and their implications is critical for patient outcomes.
Purpose of the Study:
- To quantify racial disparities in cardiac radiation dose among breast cancer patients.
- To evaluate the multilevel determinants contributing to these disparities.
- To estimate the impact of cardiac dose disparities on ischemic cardiac events and mortality.
Main Methods:
- Analysis of a statewide consortium database of 8750 women undergoing whole breast radiotherapy (2012-2018).
- Development of laterality- and fractionation-specific models for mean heart dose.
- Patient- and facility-level modeling to estimate race-specific cardiac doses and associated risks.
Main Results:
- Black and Asian women showed independently higher mean heart doses compared to White women.
- Disparities reached up to 0.42 Gy for Black women and 0.32 Gy for Asian women.
- These dose differences correlated with estimated excess cardiac events and deaths per 1000 women.
Conclusions:
- Breast cancer patients of Black and Asian race receive higher cardiac radiation doses than White patients.
- These higher doses may lead to an increased risk of radiation-associated ischemic cardiac events and mortality.
- Addressing baseline cardiac risk factors and improving access to advanced radiation technologies are potential solutions.
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
161
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
161
Imaging Studies for Cardiovascular System III: X-Ray
291
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
291

